Abstract Submission
The 2026 MSAP conference welcomes podium presentation abstracts from ideas to research in progress, to completed research. Abstracts should be scientific in nature and include sufficient information for reviewers to judge the appropriateness of the submission.
All submissions should include sufficient background, methodological description, results, discussion, and conclusions. Idea papers and research in progress can use headings as the authors deem relevant.
Abstracts should be exact in wording, and be understandable to a wide audience. Abstracts should be no more than 400 words, formatted in Microsoft Word, and single-spaced, 12-point font.
Each student attendee is limited to one abstract, although they could be co-authors on other presentations. Dual presenters are not allowed.
Required Submission Information
- The presenting author
- School
- Student level (PharmD student, Graduate Student, Resident, Fellow)
- Additional authors.
- Information required for each author: first name, last name, institutional affiliation(s), and email
- Conflict of interest statement*
- Not exceed 400 words (no tables or figures allowed).
- Structured with the following sections:
- Background & objective
- Methods
- Results (preliminary or final)
- Discussion
- Conclusion
Key words: Three required, max five words (not included in word count) to help the conference organizers with presentation room assignments.
Abstracts that do not comply with the above guidelines will be rejected. All abstracts must be received by 5 PM CDT, April 24, 2026.
* All presenters must disclose study funding sources and other commercial/financial relationships that could be perceived as a conflict of interest. If none, please list the following statement: The speaker has nothing to disclose.